Serplulimab plus Chemotherapy Improves OS and PFS in Elderly ES-SCLC
Written by
Cancer Network
Published
0
comments
0
min
The biomarker NLR may not be suitable for prognosis prediction in elderly patients with small cell lung cancer, according to this real-world study.